Good morning. I'm Andrew Dudum, Chief Executive Officer of Hims & Hers Health Inc, and it is my pleasure to welcome you to our 2024 Annual Meeting of Stockholders. We're excited to be hosting our annual meeting virtually, which allows us to reach a greater number of our stockholders via the web portal. I'd also like to welcome our directors, officers, and employees who are with us today, as well as representatives from KPMG, our auditor, and Gunderson, our outside counsel. The agenda for this meeting is as follows: I'll provide an overview of certain formal matters relating to this meeting. Next, we will collect the votes of the proposals that are the subject of this meeting, and that will conclude the formal business of the meeting. I will then field questions from attendees pertaining to the agenda, consistent with our rules of conduct. The meeting will then be concluded. It is now approximately 11:01 Pacific Time on June 6th, 2024. The meeting is now called to order. I have proof by affidavit, signed by a representative of Broadridge Financial Solutions, Inc, that notice of this meeting has been duly given, and that the notice of the 2024 Annual Meeting of Stockholders, proxy statement, and proxy card were mailed on or about April 26th, 2024, to all stockholders of record at the close of business on April 16th, 2024. The affidavit, together with copies of the notice, proxy statement, and proxy card, and other proxy materials, will be filed with the minutes of the meeting. In addition, Robert V. Johnson has signed an oath in his role as the Inspector of Elections. The Oath of Inspector of Elections will be filed with the minutes of this meeting. The Inspector of Election has advised me that we have present in person and by proxy, a sufficient number of shares to constitute a quorum, so the meeting is duly constituted and is able to transact business. We will vote by proxy ballot today. Each holder of our Class A common stock has the right to 1 vote per share of Class A common stock, and each holder of our Class V common stock has the right to 175 votes per share of Class V common stock. If you have turned in a proxy by mail, telephone, or internet and do not intend to change your vote, it is not necessary that you vote at this meeting because we will count your submitted proxy. If you did not turn in a proxy or wish to change your vote, you may also do so by clicking on the voting button on the web portal and following the instructions there. It is now approximately 11:03 A.M. Pacific Time on June 6th, 2024. The polls are now open for voting. Until the polls close, any stockholder may revoke or change his or her prior vote on any matter. However, upon the closing of the polls, no ballots, proxies, or votes, nor any revocations or changes will be accepted. The first item of formal business is the nomination and election of eight directors for a term of one year or until their respective successors have been duly elected and qualified. The term of each of our eight directors expires at the next annual meeting. The persons named in the proxy statement have been nominated to serve as directors of the company. They are Andrew Dudum, Dr. Patrick Carroll, Dr. Delos Cosgrove, Anja Manuel, Christopher Payne, Christiane Pendarvis, Andrea Perez, and David Wells. The second item of formal business is to ratify the appointment of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2024. The third item of formal business to approve on an advisory basis, the compensation of our named executive officers as set forth in our proxy statement. These are the only items of formal business of the meeting. If you wish to vote today and have not already submitted your ballot by clicking on the voting button on the web portal and following the instructions there, please do so now. It is now approximately 11:05 A.M. Pacific Time on June 6th, 2024. I hereby declare the polls closed. The ballots and proxies will be held in the possession of the Inspector of Election. Now, I will report on the results of the voting. Based upon all the proxies received prior to the commencement of the meeting, and subject to final adjustment of the numbers for any ballots collected here today, I can tell you that Andrew Dudum, Dr. Patrick Carroll, Dr. Delos Cosgrove, Anja Manuel, Christopher Payne, Christiane Pendarvis, Andrea Perez, and David Wells have been elected to the board of directors by a plurality of the votes cast to serve as directors, each for a term of one year. The appointment of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2024, has been ratified by a majority of the votes cast, and the executive compensation for our named executive officers, as set forth in our proxy statement, has been approved by a majority of the votes cast. The Inspector of Elections will conduct a final count of all votes on these matters, and the final results will be included in the minutes of this meeting. Final voting results will also be available on a current report on Form 8-K, filed with the SEC within 4 business days after the end of this annual meeting. This concludes the formal business of the meeting. At this time, we'll accept questions from stockholders or proxy holders pertaining to the agenda, consistent with our rules of conduct. If you wish to submit a question, please click on the Q&A button on the virtual stockholder portal. Each stockholder or proxy holder may submit one question. Questions will not be answered live, but we will respond to any questions by shareholders after the meeting. This concludes our meeting, and this Annual Meeting of Stockholders is hereby adjourned.